| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |